Delivery Order SPE2DB24D2205-SPE2DB26FDSYA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Copaxone 40 mg/ml syringes valued at $6,552.00, with an ultimate completion date of October 30, 2025. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,638.00 delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with a completion date of September 10, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $2,718.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with completion scheduled for September 15, 2025. This non-set-aside contract represents a competitively awarded delivery order issued under AmerisourceBergen's broader pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,580.20 to AmerisourceBergen Drug Corp for the supply of Copaxone 40 mg/ml syringes. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, utilizes firm fixed price terms and was competitively awarded without set-aside provisions. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order. This delivery order is...
- The Defense Logistics Agency awarded a $5,051.58 delivery order to AmerisourceBergen Drug Corp for COPAXONE 20 mg/ml syringes, with an ultimate completion date of September 15, 2025. This is a firm fixed price, non-set-aside contract issued on September 12, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,218.86 to supply Copaxone 40 mg/mL syringes. This competitively awarded, firm fixed-price contract, issued on October 15, 2025, with an ultimate completion date of October 16, 2025, represents a direct fulfillment of pharmaceutical needs through the company's existing indefinite delivery vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/mL syringes under a firm fixed-price contract with a ceiling value of $1,128.54. This non-set-aside award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a direct delivery order fulfillment. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. AmerisourceBergen Drug Corp, a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 22, 2025, for the supply of Copaxone 40 mg/ml syringes. This firm fixed price delivery order, valued at $2,163.92, represents a competitive award with no set-aside designation and is scheduled for completion by September 23, 2025. The contract will be performed at AmerisourceBergen's Conshohocken facility. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, valued at $1,971.90 with a firm fixed price structure. The order was competitively awarded without set-aside provisions and is scheduled for completion by September 11, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this requirement from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,683.86 to AmerisourceBergen Drug Corp for Copaxone 20 mg/ml syringes, with a completion date of August 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operates as a major...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB26FDSYADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,065.20 to AmerisourceBergen Drug Corp for the supply of Copaxone 40 mg/ml syringes. This non-competitive, firm fixed-price delivery order was issued on October 30, 2025, with an ultimate completion date of October 31, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The underlying IDC encompasses specialty medications, brand-name and generic drugs, vaccines, syringes, and related medical commodities across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 10/30/25 |